Continued Use of Effective Contraception After Use of Emergency Contraception

Women using an emergency contraceptive method must use back up protection for 1-2 weeks depending on method. The Copper-IUD is the most effective emergency contraceptive method. The investigators wish to explore if women choosing the Cooper IUD have a higher frequency of use of an effective contraceptive method 3 months and 6 months after the use of an emergency contraceptive method than women who choose to use the emergency contraceptive pill EllaOne (ulipristal acetate).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Emergency Contraception Contraception Reproductive Health

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

Primary location

RFSU clinic

Stockholm, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

women over 18 years
eligible for all emergency contraception

Exclusion criteria

previous conisation
known stenosis of the cervix
signs of ongoing genital infection
known uterine anomaly
Known bleeding disorder

Treatment and study plan

Primary outcomes

Use of an effective contraceptive method

Time frame: 6 months after emergency contraceptive use

Use of pill, patch, ring, IUD, IUS, or injection 6 months after use of emergency contraceptive method

Sponsors and collaborators

Lead sponsor

Karolinska Institutet

Other

Registry information

Important dates

Study start: 2014
Primary completion: 2015
Study completion: 2015
First posted: Mar 5, 2014
Registry last updated: Nov 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed